Ohcanbohtosat - Jill S. Clancy

  • Čájehuvvo 1 - 5 / 5
Aiddostahte ozu
  1. 1
    Randomized Phase III Trial of Temsirolimus and Bevacizumab Versus Interferon Alfa and Bevacizumab in Metastatic Renal Cell Carcinoma: INTORACT Trial

    Randomized Phase III Trial of Temsirolimus and Bevacizumab Versus Interferon Alfa and Bevacizumab in Metastatic Renal Cell Carcinoma: INTORACT Trial Dahkki Brian I. Rini, Joaquim Bellmunt, Jill S. Clancy, Kongming Wang, Andreas G. Niethammer, Hariharan Subramanian, Bernard Escudier

    Almmustuhtton 2013
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  2. 2
    Phase II trial of temsirolimus in children with high-grade glioma, neuroblastoma and rhabdomyosarcoma

    Phase II trial of temsirolimus in children with high-grade glioma, neuroblastoma and rhabdomyosarcoma Dahkki Birgit Geoerger, Mark W. Kieran, Stephan A. Grupp, Danuta Perek, Jill S. Clancy, Mizue Krygowski, Revathi Ananthakrishnan, Joseph Boni, Anna Berkenblit, Sheri L. Spunt

    Almmustuhtton 2011
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  3. 3
    Phase I Study of Temsirolimus in Pediatric Patients With Recurrent/Refractory Solid Tumors

    Phase I Study of Temsirolimus in Pediatric Patients With Recurrent/Refractory Solid Tumors Dahkki Sheri L. Spunt, Stephan A. Grupp, Terry A. Vik, Victor M. Santana, David J. Greenblatt, Jill S. Clancy, Anna Berkenblit, Mizue Krygowski, Revathi Ananthakrishnan, Joseph Boni, Richard J. Gilbertson

    Almmustuhtton 2011
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  4. 4
    Lorlatinib in non-small-cell lung cancer with ALK or ROS1 rearrangement: an international, multicentre, open-label, single-arm first-in-man phase 1 trial

    Lorlatinib in non-small-cell lung cancer with ALK or ROS1 rearrangement: an international, multicentre, open-label, single-arm first-in-man phase 1 trial Dahkki Alice T. Shaw, Enriqueta Felip, Todd M. Bauer, Benjamin Besse, Alejandro Navarro, Sophie Postel‐Vinay, Justin F. Gainor, Melissa L. Johnson, Jörg Dietrich, Leonard P. James, Jill S. Clancy, Joseph Chen, Jean‐François Martini, Antonello Abbattista, Benjamin Solomon

    Almmustuhtton 2017
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  5. 5
    <i>ALK</i> Resistance Mutations and Efficacy of Lorlatinib in Advanced Anaplastic Lymphoma Kinase-Positive Non–Small-Cell Lung Cancer

    <i>ALK</i> Resistance Mutations and Efficacy of Lorlatinib in Advanced Anaplastic Lymphoma Kinase-Positive Non–Small-Cell Lung Cancer Dahkki Alice T. Shaw, Benjamin Solomon, Benjamin Besse, Todd M. Bauer, Chia‐Chi Lin, Ross A. Soo, Gregory J. Riely, Sai‐Hong Ignatius Ou, Jill S. Clancy, Sherry Li, Antonello Abbattista, Holger Thurm, Miyako Satouchi, D. Ross Camidge, Steven Kao, Rita Chiari, Shirish M. Gadgeel, Enriqueta Felip, Jean‐François Martini

    Almmustuhtton 2019
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:

Ohcanreaiddut: